SEC Tracker
Get the app

Clorox CLX

Clorox Q1 FY25: revenue $1.8B, up 27%; diluted EPS $0.80

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers Clorox reported for Q1 FY25, the quarter ended Sep 30, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$1.8B+27% from $1.4B in Q1 FY2410-Q income statement, on EDGAR
  2. Net income$99.0M+350% from $22.0M in Q1 FY2410-Q income statement, on EDGAR
  3. Diluted EPS$0.80+371% from $0.17 in Q1 FY2410-Q income statement, on EDGAR
  4. Cash and cash equivalents$278.0M−46% from $518.0M in Q1 FY2410-Q balance sheet, on EDGAR
  5. Cash from operations$221.0M+1005% from $20.0M in Q1 FY2410-Q cash flow statement, on EDGAR

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Clorox files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2842 and related industry codes: the same peer list as the financial tables.

  1. Church & Dwight CHD public float $22.9B, Jun 30, 2025
  2. Estee Lauder Companies EL public float $26.0B, Dec 31, 2025
  3. Kenvue KVUE public float $39.6B, Jun 27, 2025
  4. Ecolab ECL public float $67.1B, Jun 30, 2025
  5. Colgate Palmolive CL public float $73.4B, Jun 30, 2025